Crucially, autophagy that can be regulated by DIRAS3 is mechanistically shown to contribute to tumor immune evasion via the lysosomal degradation of MHC class I molecules, thereby reducing the antigen presentation efficiency and impairing CD8+ cytotoxic T-lymphocyte (CTL)-mediated tumor elimination [42,43]. Here, DIRAS3 is linked to neoplasm.